digraph structs {
rankdir=LR;
g0 [shape=record,label="http://dikb.org/data-rati\lo-type/138dd5af-ec37-41f8\l-9c01-cf8f024ef0a4\lvalue specification\lobo:OBI_0001933\l|has specified value\lobo:OBI_0001937\l15\l",color=blue]
g0 -> g3 [label="\lobo:OBI_0000051\l"]
g1 [shape=record,label="http://purl.obolibrary.or\lg/obo/UO_0000187\l\lrdfs:Class\l",color=blue]
g2 [shape=record,label="http://purl.obolibrary.or\lg/obo/PATO_0000125\l\lrdfs:Class\l",color=blue]
g3 [shape=record,label="http://dikb.org/data-rati\lo-type-has-part/c547068e-\lb7a3-48ef-8ff7-3d7bd28aea\lfd\lpercent\lobo:UO_0000187\l",color=blue]
g4 [shape=record,label="http://dikb.org/object-mi\llligram/72a8da48-113f-4d4\l0-a076-38ec9e8406dd\l\lobo:UO_0000022\l",color=blue]
g5 [shape=record,label="http://dikb.org/object-dr\lug-role/8ee70bbf-8530-4e2\le-a1f6-2154dca9b567\lprecipitant drug role\lobo:DIDEO_00000013\l",color=blue]
g6 [shape=record,label="http://dikb.org/precipita\lnt-active-ingredient/a176\lf0f8-2a18-4e44-964b-e21ff\lb992e58\lactive ingredient\lobo:DRON_00000028\l",color=blue]
g7 [shape=record,label="http://dikb.org/precipita\lnt-drug-role/f93343ce-949\le-478d-bac9-f32e3dc1715a\lprecipitant drug role\lobo:DIDEO_00000013\l",color=blue]
g8 [shape=record,label="http://dikb.org/object-ma\lss/195a34d4-78a1-467b-9c1\l0-04e535a5b896\l\lobo:PATO_0000125\l",color=blue]
g9 [shape=record,label="http://purl.obolibrary.or\lg/obo/BFO_0000051\l\lrdf:Property\l",color=blue]
g10 [shape=record,label="http://purl.obolibrary.or\lg/obo/TEMO_111111\l\lrdf:Property\l",color=blue]
g11 [shape=record,label="http://dikb.org/assertion\l/ed9a5e3a-2822-459a-b8df-\l1e03b627a2dc\ldrug-drug interaction des\lcription\lobo:DIDEO_00000001\l|label\lrdfs:label\lnefazodone-digoxin intera\lction description\l",color=blue]
g11 -> g29 [label="\lobo:IAO_0000136\l"]
g11 -> g32 [label="has part\lobo:BFO_0000051\l"]
g11 -> g43 [label="has part\lobo:BFO_0000051\l"]
g11 -> g19 [label="\lobo:IAO_0000136\l"]
g12 [shape=record,label="http://purl.obolibrary.or\lg/obo/IAO_0000039\l\lrdf:Property\l",color=blue]
g13 [shape=record,label="http://www.w3.org/1999/02\l/22-rdf-syntax-ns#type\l\lrdf:Property\l",color=blue]
g14 [shape=record,label="http://dikb.org/precipita\lnt-value-specification/57\l5fc811-1060-4c6c-a212-cb6\l446d06802\lvalue specification\lobo:OBI_0001933\l|has specified value\lobo:OBI_0001937\l200\l",color=blue]
g14 -> g28 [label="\lobo:IAO_0000039\l"]
g15 [shape=record,label="http://purl.obolibrary.or\lg/obo/IAO_0000136\l\lrdf:Property\l",color=blue]
g16 [shape=record,label="http://purl.obolibrary.or\lg/obo/OBI_0000312\l\lrdf:Property\l",color=blue]
g17 [shape=record,label="http://purl.obolibrary.or\lg/obo/DIDEO_00000001\l\lrdfs:Class\l",color=blue]
g18 [shape=record,label="http://dikb.org/object-ac\ltive-ingredient/c14d3464-\l7413-45aa-a4e0-4456d58ad0\l7b\lactive ingredient\lobo:DRON_00000028\l",color=blue]
g19 [shape=record,label="http://dikb.org/bearer-pr\lecipitant/4bf9bc1b-b340-4\l285-9ec7-7ac4dc35ff12\l",color=orange]
g19 -> g7 [label="\lobo:RO_0000053\l"]
g19 -> g30 [label="has part\lobo:BFO_0000051\l"]
g20 [shape=record,label="http://purl.obolibrary.or\lg/obo/OBI_0000576\l\lrdfs:Class\l",color=blue]
g21 [shape=record,label="http://dikb.org/object-va\llue-measurement-datum/08f\la61fa-9900-4039-9211-139a\l63dc28ce\l\lobo:IAO_0000109\l",color=blue]
g21 -> g8 [label="\lobo:TEMO_111111\l"]
g21 -> g23 [label="has specified value\lobo:OBI_0001937\l"]
g22 [shape=record,label="http://purl.obolibrary.or\lg/obo/DRON_00000028\l\lrdfs:Class\l",color=blue]
g23 [shape=record,label="http://dikb.org/object-va\llue-specification/735abf3\l4-b097-44d5-bbfc-8ec344c4\l7517\lvalue specification\lobo:OBI_0001933\l|has specified value\lobo:OBI_0001937\l.2\l",color=blue]
g23 -> g4 [label="\lobo:IAO_0000039\l"]
g24 [shape=record,label="http://purl.obolibrary.or\lg/obo/RO_0002351\l\lrdf:Property\l",color=blue]
g25 [shape=record,label="http://purl.obolibrary.or\lg/obo/UO_0000022\l\lrdfs:Class\l",color=blue]
g26 [shape=record,label="http://dikb.org/precipita\lnt-value-measurement-datu\lm/15926dba-9c11-4dfa-ae8b\l-e6152590392d\l\lobo:IAO_0000109\l",color=blue]
g26 -> g33 [label="\lobo:TEMP_111111\l"]
g26 -> g14 [label="has specified value\lobo:OBI_0001937\l"]
g27 [shape=record,label="http://dikb.org/object-dr\lug/2562c57f-df02-4a45-b45\le-09df1be2ffc2\l\l\<http://purl.bioontology.\lorg/ontology/RXNORM/3407\>\l",color=blue]
g28 [shape=record,label="http://dikb.org/precipita\lnt-milligram/c50a3b78-f1a\le-49d8-8a03-d22d67577435\l\lobo:UO_0000022\l",color=blue]
g29 [shape=record,label="http://dikb.org/bearer-ob\lject/c7083948-749e-4de3-8\lcb0-a63c0b539987\l",color=orange]
g29 -> g37 [label="has part\lobo:BFO_0000051\l"]
g29 -> g5 [label="\lobo:RO_0000053\l"]
g30 [shape=record,label="http://dikb.org/p-scatter\led-molecular-aggregate/b6\l877750-07b5-4645-955a-15f\ld6d2b780d\lscattered molecular aggre\lgate\lobo:OBI_0000576\l",color=blue]
g30 -> g6 [label="\lobo:RO_0000053\l"]
g30 -> g36 [label="\lobo:RO_0002351\l"]
g30 -> g26 [label="\lobo:RO_0000053\l"]
g31 [shape=record,label="http://dikb.org/data-rati\lo-type-has-part/543e9b52-\l1686-4204-bf67-fe4845b2ba\l00\lpercent\lobo:UO_0000187\l",color=blue]
g32 [shape=record,label="http://dikb.org/data-rati\lo/0d9ed367-b872-4230-a486\l-ae82e40743aa\linformation about increas\le of pharmacokinetic area\l under the curve\lobo:DIDEO_00000050\l|label\lrdfs:label\lnefazodone-digoxin drug p\lackage auc Increase infor\lmation\l",color=blue]
g32 -> g0 [label="has specified value\lobo:OBI_0001937\l"]
g32 -> g44 [label="is_specified_output_of\lobo:OBI_0000312\l"]
g33 [shape=record,label="http://dikb.org/precipita\lnt-mass/31d7b55e-2388-494\la-9fcc-1ba4431501af\l\lobo:PATO_0000125\l",color=blue]
g34 [shape=record,label="http://purl.obolibrary.or\lg/obo/TEMP_METHOD_CODE\l\lrdfs:Class\l",color=blue]
g35 [shape=record,label="http://www.w3.org/2000/01\l/rdf-schema#label\l\lrdf:Property\l",color=blue]
g36 [shape=record,label="http://dikb.org/precipita\lnt-drug/98925eb7-cc0e-4d9\le-a603-fefa658605dc\l\l\<http://purl.bioontology.\lorg/ontology/RXNORM/31565\l\>\l",color=blue]
g37 [shape=record,label="http://dikb.org/o-scatter\led-molecular-aggregate/3b\lf4c22b-daaa-4d10-abbf-196\lf633f8f71\lscattered molecular aggre\lgate\lobo:OBI_0000576\l",color=blue]
g37 -> g27 [label="\lobo:RO_0002351\l"]
g37 -> g21 [label="\lobo:RO_0000053\l"]
g37 -> g18 [label="\lobo:RO_0000053\l"]
g38 [shape=record,label="http://purl.obolibrary.or\lg/obo/OBI_0001937\l\lrdf:Property\l",color=blue]
g39 [shape=record,label="http://purl.obolibrary.or\lg/obo/TEMP_111111\l\lrdf:Property\l",color=blue]
g40 [shape=record,label="http://purl.obolibrary.or\lg/obo/OBI_0001933\l\lrdfs:Class\l",color=blue]
g41 [shape=record,label="http://dikb.org/data-rati\lo-type/7bde6fde-b7ee-4c83\l-bfab-ef0d52df9739\lvalue specification\lobo:OBI_0001933\l|has specified value\lobo:OBI_0001937\l29\l",color=blue]
g41 -> g31 [label="\lobo:OBI_0000051\l"]
g42 [shape=record,label="http://purl.obolibrary.or\lg/obo/DIDEO_00000013\l\lrdfs:Class\l",color=blue]
g43 [shape=record,label="http://dikb.org/data-rati\lo/0832f3ed-d681-4e75-9e9b\l-6b4e7037d902\linformation about increas\le of pharmacokinetic area\l under the curve\lobo:DIDEO_00000050\l|label\lrdfs:label\lnefazodone-digoxin drug p\lackage cmax Increase info\lrmation\l",color=blue]
g43 -> g44 [label="is_specified_output_of\lobo:OBI_0000312\l"]
g43 -> g41 [label="has specified value\lobo:OBI_0001937\l"]
g44 [shape=record,label="http://dikb.org/method/7e\ladbdb5-9f24-4675-90bc-928\l06919a380\l\lobo:TEMP_METHOD_CODE\l|label\lrdfs:label\lnefazodone-digoxin DDI cl\linical trial\l",color=blue]
g45 [shape=record,label="http://purl.obolibrary.or\lg/obo/OBI_0000051\l\lrdf:Property\l",color=blue]
g46 [shape=record,label="http://purl.obolibrary.or\lg/obo/IAO_0000109\l\lrdfs:Class\l",color=blue]
g47 [shape=record,label="http://purl.obolibrary.or\lg/obo/DIDEO_00000050\l\lrdfs:Class\l",color=blue]
g48 [shape=record,label="http://purl.obolibrary.or\lg/obo/RO_0000053\l\lrdf:Property\l",color=blue]
}